BipinNSavaniMD

PubMed

• Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions.
  Jeremy W Jacobs, Garrett S Booth, Sheharyar Raza, Landon M Clark, Ross M Fasano
  American Journal of Hematology. 2024-12-01
• Progressive multifocal leukoencephalopathy after CAR-T cell therapy.
  Michael Montoya, Hannah J Harmsen, Brittney Baer, Nancy Long, Amy Messimore
  Bone Marrow Transplantation. 2024-12-01
• Evaluating Antibiotic De-escalation for Autologous Stem Cell Transplant Patients With Febrile Neutropenia in a Real-World Clinical Setting.
  Marshall D Winget, Katie Gatwood, Reena Jayani, Eden Biltibo, Andrew Jallouk
  Transplantation and Cellular Therapy. 2024-10-01

Journal Articles

• The European Society for Blood and Marrow Transplantation (EBMT) Consensus Recommendations for Donor Selection in Haploidentical Hematopoietic Cell Transplantation  
  Leo Luznik, Karen Ballen, Asad Bashey, Hillard M Lazarus, Bipin N Savani, Rizwan Romee, Ephraim J Fuchs, Nature
• Prophylactic Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplantation in Acute Leukaemia – a Matched Pair Analysis by the Acute Leukaemia Working Party of ...  
  Bipin Savani, MD, British Journal of Haematology
• Post-Remission Strategies for the Prevention of Relapse Following Allogeneic Hematopoietic Cell Transplantation for High-Risk Acute Myeloid Leukemia: Expert Review fro...  
  Catherine J Lee, Bipin N Savani, Nature
• Comparison of FLAMSA-Based Reduced Intensity Conditioning with treosulfan/fludarabine Conditioning for Patients with Acute Myeloid Leukemia: An ALWP/EBMT Analysis  
  Bipin Savani, MD, Nature
• Join now to see all

Abstracts/Posters

• Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Karnofsky Performance Status Score Equal or Lower Than 80%. a Study from...
  Bipin N. Savani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Lower Hematopoietic Progenitor Cell Counts and Yields at Subsequent Donations Is Influenced By a Shorter Inter-Donation Interval between the First and Subsequent Mobil...
  Bipin N. Savani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Outcomes of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning Regimen in Haploidentical Hematopoietic Cell Transplantation with Post-Transpl...
  Bipin N. Savani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Outcome of Two Loci Mismatched (_6/8) Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia: ALWP of the EBMT Study
  Bipin N. Savani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Karnofsky Performance Status Score Equal or Lower Than 80%. a Study from...
  Bipin N. Savani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Impact of Renal Dysfunction Measured By Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)
  Bipin N. Savani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Venetoclax-Based Salvage Therapy for Post-Hematopoietic Cell Transplantation Relapse in Acute Myeloid Leukemia
  Bipin N. Savani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• The Disease-Risk Stratification Scheme (DRSS), a Contemporary Risk-Stratification System for Allogeneic Stem Cell TransplantationClinically Relevant Abstract
  Bipin N. Savani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from HLA-Identic...
  Bipin N. Savani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Inferior Outcome of Allogeneic Stem Cell Transplantation in First Complete Remission for Secondary AML As Compared to De Novo Disease: Results from a Retrospective, Re... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018